Skip to content

Target for improvement: A cluster randomized trial of public involvement in quality indicator prioritization.

Target for improvement: A cluster randomized trial of public involvement in quality indicator prioritization.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24769
Enrollment
200
Registered
2010-08-31
Start date
2010-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Public involvement, quality improvement, quality indicator, chronic disease prevention and management

Interventions

In intervention sites, public representatives participate in a one-day deliberation meeting on quality indicator prioritization along with clinicians and managers. In control groups, quality indicator

Sponsors

Scientific Institute for Quality of Healthcare (114) Radboud University Nijmegen Medical Centre P.O. Box 9101, 114 IQ healthcare 6500 HB Nijmegen The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Public representatives: A. Be 18 year old or older; B. Live within the catchment area of a participating site; C. Have a good capacity for sharing opinions with others. 2. Professionals: A. Work as a clinician or manager in relation with the prevention or management of chronic diseases; B. Work within the catchment area of a participating health authority; C. Have a good capacity for sharing opinions with others. 3. Decision-maker: person identified by the director-general of a local health authority to advise him/her on the choice of quality indicator.

Exclusion criteria

Exclusion criteria: Public representative: Be currently or previously working as a health professional or health manager.

Design outcomes

Primary

MeasureTime frame
Our primary outcome will assess the impact of public involvement on quality indicator choice and agreement with public priorities.

Secondary

MeasureTime frame
1. Decision-makers' intention to use the indicators; 2. Financial cost of the intervention; 3. Process evaluation will be conducted throughout the trial to explain results, through direct observation of meetings, videorecording of discussions, and assessment of participants' experience.

Contacts

Public ContactAntoine Bolvin

Scientific Institute for Quality of Healthcare

antoine.boivin@gmail.com+31 (0)819 764 3264

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)